SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Costello David M.) srt2:(2020-2024)"

Sökning: WFRF:(Costello David M.) > (2020-2024)

  • Resultat 1-10 av 13
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Costello, David M., et al. (författare)
  • Global patterns and controls of nutrient immobilization on decomposing cellulose in riverine ecosystems
  • 2022
  • Ingår i: Global Biogeochemical Cycles. - : John Wiley & Sons. - 0886-6236 .- 1944-9224. ; 36:3
  • Tidskriftsartikel (refereegranskat)abstract
    • Microbes play a critical role in plant litter decomposition and influence the fate of carbon in rivers and riparian zones. When decomposing low-nutrient plant litter, microbes acquire nitrogen (N) and phosphorus (P) from the environment (i.e., nutrient immobilization), and this process is potentially sensitive to nutrient loading and changing climate. Nonetheless, environmental controls on immobilization are poorly understood because rates are also influenced by plant litter chemistry, which is coupled to the same environmental factors. Here we used a standardized, low-nutrient organic matter substrate (cotton strips) to quantify nutrient immobilization at 100 paired stream and riparian sites representing 11 biomes worldwide. Immobilization rates varied by three orders of magnitude, were greater in rivers than riparian zones, and were strongly correlated to decomposition rates. In rivers, P immobilization rates were controlled by surface water phosphate concentrations, but N immobilization rates were not related to inorganic N. The N:P of immobilized nutrients was tightly constrained to a molar ratio of 10:1 despite wide variation in surface water N:P. Immobilization rates were temperature-dependent in riparian zones but not related to temperature in rivers. However, in rivers nutrient supply ultimately controlled whether microbes could achieve the maximum expected decomposition rate at a given temperature. Collectively, we demonstrated that exogenous nutrient supply and immobilization are critical control points for decomposition of organic matter.
  •  
2.
  • Aughton, Karen, et al. (författare)
  • hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
  • 2021
  • Ingår i: Cancers. - : MDPI. - 2072-6694. ; 13:22
  • Tidskriftsartikel (refereegranskat)abstract
    • Gemcitabine or 5-fluorouracil (5-FU) based treatments can be selected for pancreatic cancer. Equilibrative nucleoside transporter 1 (hENT1) predicts adjuvant gemcitabine treatment benefit over 5-FU. Cytidine deaminase (CDA), inside or outside of the cancer cell, will deaminate gemcitabine, altering transporter affinity. ESPAC-3(v2) was a pancreatic cancer trial comparing adjuvant gemcitabine and 5-FU. Tissue microarray sections underwent in situ hybridization and immunohistochemistry. Analysis of both CDA and hENT1 was possible with 277 patients. The transcript did not correlate with protein levels for either marker. High hENT1 protein was prognostic with gemcitabine; median overall survival was 26.0 v 16.8 months (p = 0.006). Low CDA transcript was prognostic regardless of arm; 24.8 v 21.2 months with gemcitabine (p = 0.02) and 26.4 v 14.6 months with 5-FU (p = 0.02). Patients with low hENT1 protein did better with 5-FU, but only if the CDA transcript was low (median survival of 5-FU v gemcitabine; 29.3 v 18.3 months, compared with 14.2 v 14.6 with high CDA). CDA mRNA is an independent prognostic biomarker. When added to hENT1 protein status, it may also provide treatment-specific predictive information and, within the frame of a personalized treatment strategy, guide to either gemcitabine or 5FU for the individual patient.Simple Summary:Recent clinical trials suggest that combination therapies that include either gemcitabine or 5-fluorouracil (5-FU) both give significant survival benefits for pancreatic cancer patients. The tumor level of the nucleoside transporter hENT1 is prognostic in patients treated with adjuvant gemcitabine but not adjuvant 5-FU. This work shows for the first time that hENT1 is only predictive of benefit from gemcitabine over 5-FU in patients with low levels of CDA transcript. A choice between adjuvant 5-FU based combination therapies (such as FOLFIRINOX) and gemcitabine-based therapy (e.g., GemCap) could be made based on a combination of hENT1 protein and CDA mRNA measured in a resected tumor.
  •  
3.
  • Heaney, Liam G., et al. (författare)
  • Eosinophilic and Noneosinophilic Asthma : An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort
  • 2021
  • Ingår i: Chest. - : Elsevier BV. - 0012-3692. ; 160:3, s. 814-830
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Phenotypic characteristics of patients with eosinophilic and noneosinophilic asthma are not well characterized in global, real-life severe asthma cohorts. Research Question: What is the prevalence of eosinophilic and noneosinophilic phenotypes in the population with severe asthma, and can these phenotypes be differentiated by clinical and biomarker variables? Study Design and Methods: This was an historical registry study. Adult patients with severe asthma and available blood eosinophil count (BEC) from 11 countries enrolled in the International Severe Asthma Registry (January 1, 2015-September 30, 2019) were categorized according to likelihood of eosinophilic phenotype using a predefined gradient eosinophilic algorithm based on highest BEC, long-term oral corticosteroid use, elevated fractional exhaled nitric oxide, nasal polyps, and adult-onset asthma. Demographic and clinical characteristics were defined at baseline (ie, 1 year before or closest to date of BEC). Results: One thousand seven hundred sixteen patients with prospective data were included; 83.8% were identified as most likely (grade 3), 8.3% were identified as likely (grade 2), and 6.3% identified as least likely (grade 1) to have an eosinophilic phenotype, and 1.6% of patients showed a noneosinophilic phenotype (grade 0). Eosinophilic phenotype patients (ie, grades 2 or 3) showed later asthma onset (29.1 years vs 6.7 years; P < .001) and worse lung function (postbronchodilator % predicted FEV1, 76.1% vs 89.3%; P = .027) than those with a noneosinophilic phenotype. Patients with noneosinophilic phenotypes were more likely to be women (81.5% vs 62.9%; P = .047), to have eczema (20.8% vs 8.5%; P = .003), and to use anti-IgE (32.1% vs 13.4%; P = .004) and leukotriene receptor antagonists (50.0% vs 28.0%; P = .011) add-on therapy. Interpretation: According to this multicomponent, consensus-driven, and evidence-based eosinophil gradient algorithm (using variables readily accessible in real life), the severe asthma eosinophilic phenotype was more prevalent than previously identified and was phenotypically distinct. This pragmatic gradient algorithm uses variables readily accessible in primary and specialist care, addressing inherent issues of phenotype heterogeneity and phenotype instability. Identification of treatable traits across phenotypes should improve therapeutic precision.
  •  
4.
  • Mitchell, David G.M., et al. (författare)
  • Spatially Coupled Generalized LDPC Codes : Asymptotic Analysis and Finite Length Scaling
  • 2021
  • Ingår i: IEEE Transactions on Information Theory. - 0018-9448. ; 67:6, s. 3708-3723
  • Tidskriftsartikel (refereegranskat)abstract
    • Generalized low-density parity-check (GLDPC) codes are a class of LDPC codes in which the standard single parity check (SPC) constraints are replaced by constraints defined by a linear block code. These stronger constraints typically result in improved error floor performance, due to better minimum distance and trapping set properties, at a cost of some increased decoding complexity. In this paper, we study spatially coupled generalized low-density parity-check (SC-GLDPC) codes and present a comprehensive analysis of these codes, including: (1) an iterative decoding threshold analysis of SC-GLDPC code ensembles demonstrating capacity approaching thresholds via the threshold saturation effect; (2) an asymptotic analysis of the minimum distance and free distance properties of SC-GLDPC code ensembles, demonstrating that the ensembles are asymptotically good; and (3) an analysis of the finite-length scaling behavior of both GLDPC block codes and SC-GLDPC codes based on a peeling decoder (PD) operating on a binary erasure channel (BEC). Results are compared to GLDPC block codes, and the advantages and disadvantages of SC-GLDPC codes are discussed.
  •  
5.
  • Porsbjerg, Celeste M., et al. (författare)
  • Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
  • 2024
  • Ingår i: Frontiers in Immunology. - : Frontiers Media S.A.. - 1664-3224. ; 15
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: To date, studies investigating the association between pre-biologic biomarker levels and post-biologic outcomes have been limited to single biomarkers and assessment of biologic efficacy from structured clinical trials.Aim: To elucidate the associations of pre-biologic individual biomarker levels or their combinations with pre-to-post biologic changes in asthma outcomes in real-life.Methods: This was a registry-based, cohort study using data from 23 countries, which shared data with the International Severe Asthma Registry (May 2017-February 2023). The investigated biomarkers (highest pre-biologic levels) were immunoglobulin E (IgE), blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO). Pre- to approximately 12-month post-biologic change for each of three asthma outcome domains (i.e. exacerbation rate, symptom control and lung function), and the association of this change with pre-biologic biomarkers was investigated for individual and combined biomarkers.Results: Overall, 3751 patients initiated biologics and were included in the analysis. No association was found between pre-biologic BEC and pre-to-post biologic change in exacerbation rate for any biologic class. However, higher pre-biologic BEC and FeNO were both associated with greater post-biologic improvement in FEV1 for both anti-IgE and anti-IL5/5R, with a trend for antiI-IL4R alpha. Mean FEV1 improved by 27-178 mL post-anti-IgE as pre-biologic BEC increased (250 to 1000 cells/mu L), and by 43-216 mL and 129-250 mL post-anti-IL5/5R and - anti- IL4R alpha, respectively along the same BEC gradient. Corresponding improvements along a FeNO gradient (25-100 ppb) were 41-274 mL, 69-207 mL and 148-224 mL for anti-IgE, anti-IL5/5R, and anti-IL4R alpha, respectively. Higher baseline BEC was also associated with lower probability of uncontrolled asthma (OR 0.392; p=0.001) post-biologic for anti-IL5/5R. Pre-biologic IgE was a poor predictor of subsequent pre-to-post-biologic change for all outcomes assessed for all biologics. The combination of BEC + FeNO marginally improved the prediction of post-biologic FEV1 increase (adjusted R-2: 0.751), compared to BEC (adjusted R-2: 0.747) or FeNO alone (adjusted R-2: 0.743) (p=0.005 and <0.001, respectively); however, this prediction was not improved by the addition of IgE.Conclusions: The ability of higher baseline BEC, FeNO and their combination to predict biologic-associated lung function improvement may encourage earlier intervention in patients with impaired lung function or at risk of accelerated lung function decline.
  •  
6.
  • Saba, Luca, et al. (författare)
  • Carotid plaque-RADS : a novel stroke risk classification system
  • 2024
  • Ingår i: JACC Cardiovascular Imaging. - : Elsevier. - 1936-878X .- 1876-7591. ; 17:1, s. 62-75
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Carotid artery atherosclerosis is highly prevalent in the general population and is a well-established risk factor for acute ischemic stroke. Although the morphological characteristics of vulnerable plaques are well recognized, there is a lack of consensus in reporting and interpreting carotid plaque features.Objectives: The aim of this document is to establish a consistent and comprehensive approach for imaging and reporting carotid plaque by introducing the Plaque–Reporting and Data System (RADS) score.Methods: A panel of experts recognized the necessity to develop a classification system for carotid plaque and its defining characteristics. Using a multimodality analysis approach, the Plaque-RADS categories were established through consensus, drawing on existing published reports.Results: The authors present a universal classification that is applicable to both researchers and clinicians. The Plaque-RADS score offers a morphological assessment in addition to the prevailing quantitative parameter of “stenosis.” The Plaque-RADS score spans from grade 1 (indicating complete absence of plaque) to grade 4 (representing complicated plaque). Accompanying visual examples are included to facilitate a clear understanding of the Plaque-RADS categories.Conclusions: Plaque-RADS is a standardized and reliable system of reporting carotid plaque composition and morphology via different imaging modalities, such as ultrasound, computed tomography, and magnetic resonance imaging. This scoring system has the potential to help in the precise identification of patients who may benefit from exclusive medical intervention and those who require alternative treatments, thereby enhancing patient care. A standardized lexicon and structured reporting promise to enhance communication between radiologists, referring clinicians, and scientists.
  •  
7.
  • Zhu, Min, et al. (författare)
  • A Novel Design of Spatially Coupled LDPC Codes for Sliding Window Decoding
  • 2020
  • Ingår i: 2020 IEEE International Symposium on Information Theory, ISIT 2020.
  • Konferensbidrag (refereegranskat)abstract
    • We introduce a novel design of spatially coupled low density parity check codes in order to reduce the effects of error propagation in low-latency sliding window decoding for large frame lengths or streaming applications. Specifically, we employ reduced-degree check nodes spaced throughout the coupling chain, which have the effect of allowing the decoder to recover from error bursts. A simplified analysis of the block error rate (BLER) of the proposed codes is presented that allows us to predict the effect of different placements of reduced-degree checks in the coupling chain. Simulation results supporting the beneficial effect of the new code design on the overall BLER performance are included.
  •  
8.
  • Zhu, Min, et al. (författare)
  • Adaptive doping of spatially coupled LDPC codes
  • 2021
  • Ingår i: 2020 IEEE Information Theory Workshop, ITW 2020. - 9781728159638 - 9781728159621
  • Konferensbidrag (refereegranskat)abstract
    • In this paper, we study the problem of error propagation in sliding window decoding (SWD) of spatially coupled LDPC (SC-LDPC) codes. A general decoder model that accounts for error propagation is proposed and analyzed, and the decoded block error rate (BLER) is calculated using the model. In order to improve the BLER performance under decoder error propagation conditions, adaptive variable node (VN) doping is proposed, assuming a noiseless binary feedback channel is available. Example calculations using the proposed model, as well as numerical simulation results, are used to show that adaptive VN doping improves the BLER performance compared to the periodic VN doping and to the undoped case.
  •  
9.
  • Zhu, Min, et al. (författare)
  • Braided Convolutional Self-orthogonal Codes with Double Sliding Window Decoding
  • 2023
  • Ingår i: 2023 12th International Symposium on Topics in Coding, ISTC 2023. - 9798350326116
  • Konferensbidrag (refereegranskat)abstract
    • In this paper, we investigate a class of braided convolutional codes (BCCs), where the component codes are convolutional self-orthogonal codes (CSOCs), called braided convolutional self-orthogonal codes. Compared to conventional BCCs, the advantages of braided CSOCs include the availability of several low-complexity decoding methods and the relative ease of extending these methods to high rates More specifically, to construct high-rate braided codes, it is necessary to use higher-rate component codes, which results in exponentially higher decoding complexity with conventional BCJR decoding, whereas the complexity of the CSOC decoding methods proposed here grows only linearly with rate. In particular, we introduce a double sliding window decoding method based on belief propagation (BP) for braided CSOCs, which exhibits good performance while maintaining low-complexity decoding for the higher rates required in many applications.
  •  
10.
  • Zhu, Min, et al. (författare)
  • Decoder Error Propagation Mitigation for Spatially Coupled LDPC Codes
  • 2021
  • Ingår i: International Symposium on Information Theory and Its Applications, ISITA 2020. - 9781728128559 - 9784885523304 ; , s. 175-179
  • Konferensbidrag (refereegranskat)abstract
    • In this paper, we introduce two new methods of mit- igating decoder error propagation for low-latency sliding window decoding (SWD) of spatially coupled low-density parity-check (SC- LDPC) codes. Building on the recently introduced idea of check node (CN) doping of regular SC-LDPC codes, here we employ variable node (VN) doping to fix (set to a known value) a subset of variable nodes in the coupling chain. Both of these doping methods have the effect of allowing SWD to recover from error propagation, at a cost of a slight rate loss. Experimental results show that, similar to CN doping, VN doping improves performance by up to two orders of magnitude compared to un-doped SC-LDPC codes in the typical signal-to-noise ratio operating range. Further, compared to CN doping, VN doping has the advantage of not requiring any changes to the decoding process. In addition, a log- likelihood-ratio based window extension algorithm is proposed to reduce the effect of error propagation. Using this approach, we show that decoding latency can be reduced by up to a significant fraction without suffering any loss in performance.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 13

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy